https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-02023-y
0
0
Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review - Cardiovascular Diabetology - Cardiovascular Diabetology
11/16/23 at 2:52pm
Organization
Biomedcentral.com
Authors
Details
66 words
Summarize
Endocrine Conditions Diabetes Health Background Heart failure Cardiovascular Diabetology
Background Heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus (T2DM) are common and interrelated conditions, each with a significant burden of disease. HF and kidney disease progress through pathophysiologic pathways that culminate…
Create an account or login to join the discussion